By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Heptares 

1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Heptares Launches "Orbit" Initiative - A New Collaborative Drug R&D Programme For Industry And Academia Focused On G Protein-Coupled Receptors (GPCRS) 2/2/2016 10:11:50 AM
Heptares Enters Strategic Drug Discovery Collaboration With Pfizer (PFE) Focused On GPCR Targets Across Multiple Therapeutic Areas 11/30/2015 6:26:42 AM
Pfizer (PFE) Inks $1.89 Billion Discovery Deal with Heptares, Takes $33 Million Stake in Sosei 11/30/2015 5:57:26 AM
Sosei Group Corporation Subsidiary Heptares Awarded $5.5 Million Research & Development Grant From National Institute on Drug Abuse (NIDA) 9/28/2015 1:18:02 PM
Heptares Awarded $5.5 Million Research & Development Grant From The U.S. National Institute on Drug Abuse (NIDA) 9/28/2015 8:23:44 AM
AstraZeneca PLC (AZN) Emphasizes Immuno-Oncology with $510 Million+ Deal With Heptares 8/6/2015 6:11:00 AM
Sosei Subsidiary Heptares Announces Positive Outcome Of Phase 1a Study With First-Ever Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer's Disease 6/17/2015 11:16:21 AM
Heptares Announces Positive Outcome Of Phase 1A Study With First-Ever Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer's Disease 6/17/2015 6:20:06 AM
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015 5:54:15 AM
Heptares Scientists To Receive The Malcolm Campbell Memorial Prize For 2015 In Recognition Of Their Outstanding Contribution To GPCR Drug Discovery 1/27/2015 11:45:42 AM
123456
//-->